Skip to search formSkip to main contentSkip to account menu

Razadyne

Known as: Ortho McNeil Neurologics Brand of Galantamine, Ortho-McNeil Neurologics Brand of Galantamine, Reminyl 
Name of the FDA approved preparation from J&J.
National Institutes of Health

Related topics

Related topics

4 relations
24 HR galantamine hydrobromide 16 MG Extended Release Oral Capsule [Razadyne]Galantamine 8 MG Oral Tablet [Razadyne]

Broader (2)

Galantaminegalantamine hydrobromide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Jeffrey Scott Nye
Depression is a leading cause of disease burden, yet current therapies fully treat <50% of affected individuals. Increasing… 
Review
2010
Review
2010
Neurochemical basis for symptomatic treatment of Alzheimer's disease
Highly Cited
2010
Highly Cited
2010
Effects of Donepezil,Galantamine and Rivastigmine in 938 Italian Patients with Alzheimer’s Disease
AbstractBackground: Acetylcholinesterase inhibitors (AChEIs) have been used to improve cognitive status and disability in… 
Highly Cited
2009
Highly Cited
2009
Ground state of a tightly bound composite dimer immersed in a Fermi sea
In this paper we present a theoretical investigation for the ground state of an impurity immersed in a Fermi sea. The molecular… 
Highly Cited
2009
Highly Cited
2009
Galantamine inhibits β-amyloid aggregation and cytotoxicity
Highly Cited
2007
Highly Cited
2007
Melting line of the Lennard-Jones system, infinite size, and full potential.
Literature estimates of the melting curve of the Lennard-Jones system vary by as much as 10%. The origin of such discrepancies… 
Review
2006
Review
2006
Galantamine for vascular cognitive impairment.
BACKGROUND Vascular dementia is the second most common form of dementia. Cholinesterase inhibitors modestly improve a broad range… 
Highly Cited
2003
Highly Cited
2003
Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors
Galantamine (Reminyl), an approved treatment for Alzheimer's disease (AD), is a potent allosteric potentiating ligand (APL) of… 
Highly Cited
2002
Highly Cited
2002
Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophrenia.
Because of the demonstration of a selective alpha nicotinic receptor abnormality in patients with schizophrenia, galantamine was… 
Highly Cited
1999
Highly Cited
1999
Development of a Pilot Scale Process for the Anti-Alzheimer Drug (−)-Galanthamine Using Large-Scale Phenolic Oxidative Coupling and Crystallisation-Induced Chiral Conversion
(−)-Galanthamine has been synthesised using an efficient nine-step procedure, which in large scale affords 12.4 (6.7−19.1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)